Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow
https://doi.org/10.24411/0235W2990W2019W10006
About the Authors
A. V. AlekhinRussian Federation
G. P. Arutyunov
Russian Federation
S. F. Bagnenko
Russian Federation
A. Zh. Bayalieva
Russian Federation
M. V. Zhuravleva
Russian Federation
A. D. Kaprin
Russian Federation
O. N. Kotenko
Russian Federation
V. V. Krylov
Russian Federation
Yu. V. Miroshnichenko
Russian Federation
I. V. Molchanov
Russian Federation
S. V. Natarov
Russian Federation
E. E. Petryaykina
Russian Federation
Yu. S. Polushin
Russian Federation
D. N. Protsenko
Russian Federation
A. A. Skopets
Russian Federation
S. V. Sidorenko
Russian Federation
A. V. Shchegolev
Russian Federation
M. Sh. Khubutia
Russian Federation
S. M. Yudin
Russian Federation
S. V. Yakovlev
Russian Federation
Review
For citations:
Alekhin AV, Arutyunov GP, Bagnenko SF, Bayalieva AZ, Zhuravleva MV, Kaprin AD, Kotenko ON, Krylov VV, Miroshnichenko YV, Molchanov IV, Natarov SV, Petryaykina EE, Polushin YS, Protsenko DN, Skopets AA, Sidorenko SV, Shchegolev AV, Khubutia MS, Yudin SM, Yakovlev SV. Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2019;64(1-2):34-36. (In Russ.) https://doi.org/10.24411/0235W2990W2019W10006
Views:
346
Email this article 